Susan Phan

Title: Susan Phan: Innovator in RNAi Therapeutics

Introduction

Susan Phan is a prominent inventor based in Fitchburg, WI (US). She has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) agents. Her work focuses on innovative solutions for treating genetic disorders, showcasing her dedication to advancing medical science.

Latest Patents

Susan Phan holds a patent for "RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use." This patent describes RNAi agents and compositions that include these agents, aimed at inhibiting the expression of the double homeobox 4 (DUX4) gene. The DUX4 RNAi agents and conjugates disclosed in her patent effectively inhibit DUX4 gene expression. The pharmaceutical compositions that incorporate these agents can provide therapeutic benefits to individuals suffering from skeletal muscle-related diseases, including Facioscapulohumeral Muscular Dystrophy (FSHD).

Career Highlights

Susan is currently employed at Arrowhead Pharmaceuticals, Inc., where she continues to develop groundbreaking therapies. Her innovative approach and expertise in RNAi technology have positioned her as a key player in the biotechnology sector.

Collaborations

Throughout her career, Susan has collaborated with notable colleagues, including Zhi-Ming Ding and Jonathan Van Dyke. These partnerships have further enhanced her research and development efforts in the field of RNA therapeutics.

Conclusion

Susan Phan's contributions to RNAi technology and her commitment to addressing genetic disorders highlight her as a leading inventor in the biotechnology industry. Her work not only advances scientific knowledge but also holds the potential to improve the lives of many individuals affected by genetic diseases.